Table 5.
Cell type with its viability grouped according to materials used in five categories (from 0 to 21 days) and expressed in percentage of cells survival.
| Cell type | Cell viability (%) | References | Cell type | Cell viability (%) | References | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 d | 1 d | 3 d | 7 d | 21 d | 0 d | 1 d | 3 d | 7 d | 21 d | |||||
| Alginate | Chondrocytes | 79.00 | Yang et al., 2017 | MSCs | 61.00 | 78.50 | Schütz et al., 2017 | |||||||
| 90.50 | Kundu et al., 2015 | 85.02 | Freeman and Kelly, 2017 | |||||||||||
| 83.30 | 82.00 | 80.66 | 80.30 | Kosik-Kozioł et al., 2017 | 71.50 | Gonzalez-Fernandez et al., 2019 | ||||||||
| 72.00 | 85.00 | Markstedt et al., 2015 | 88.50 | 86.00 | Ji et al., 2019 | |||||||||
| 93.00 | 97.00 | 93.00 | López-Marcial et al., 2018 | HUVECs | 91.00 | 93.00 | He et al., 2018 | |||||||
| L929 | 94.00 | 97.00 | 95.00 | Li et al., 2017 | 80.00 | 78.00 | 90.00 | Maiullari et al., 2018 | ||||||
| 97.80 | 95.10 | 91.40 | Gao et al., 2017 | 97.00 | 98.00 | Campbell et al., 2015 | ||||||||
| 92.90 | 84.70 | 67.10 | Gao et al., 2015 | ADMSC | 37.50 | 79.00 | 87.50 | 68.50 | Narayanan et al., 2016 | |||||
| 87.00 | 86.50 | Ooi et al., 2018 | ATDC5 | 85.00 | 82.50 | 82.50 | 82.50 | 87.50 | Izadifar et al., 2016 | |||||
| 96.00 | 96.00 | 98.00 | 97.00 | Blaeser et al., 2013 | BxPC3 | 46.50 | 59.50 | 82.50 | Habib et al., 2018 | |||||
| 3T3 | 69.00 | 60.00 | 54.21 | Wu Y. et al., 2018 | ||||||||||
| *Khalil and Sun, 2009; Jia et al., 2014; Nguyen et al., 2017; Ahlfeld et al., 2018; Hafeez et al., 2018; Raddatz et al., 2018; Jeon et al., 2019; Yoon et al., 2019 | ||||||||||||||
| Gelatin | HUVECs | 34.60 | 57.60 | Irvine et al., 2015 | NIH3T3 | 95.90 | Shin et al., 2018 | |||||||
| C2C12 | 93.30 | 69.60 | Li et al., 2018ca | Bladder Ucs | 93.80 | 78.90 | 81.40 | Zhang K. et al., 2016 | ||||||
| hTMSCs | 96.00 | 95.00 | 90.00 | Das et al., 2015 | ||||||||||
| *Aied et al., 2018; Tijore et al., 2018a,b; Yan et al., 2018 | ||||||||||||||
| GelMA | C2C12 | 96.00 | 95.00 | Li et al., 2018cb | HepG2 | 98.61 | 98.72 | 98.92 | Billiet et al., 2014 | |||||
| 42.00 | García-Lizarribar et al., 2018 | 81.60 | 92.00 | 83.30 | Bertassoni et al., 2014 | |||||||||
| 98.30 | 80.60 | 89.70 | Zhou et al., 2019 | BMSCs | 91.80 | 92.10 | 94.90 | Du et al., 2015 | ||||||
| Chondrocytes | 91.80 | 88.50 | 88.30 | Gu et al., 2018 | 75.00 | 90.00 | Levato et al., 2017 | |||||||
| 81.00 | 77.50 | Schuurman et al., 2013 | NIH3T3 | 95.00 | Ersumo et al., 2016 | |||||||||
| *Suntornnond et al., 2017; Pepelanova et al., 2018; Haring et al., 2019; Noh et al., 2019 | ||||||||||||||
| AlginateGelatin | MSCs | 92.30 | Giuseppe et al., 2017 | Myoblasts | 95.00 | 95.30 | Chung et al., 2013 | |||||||
| L929 | 92.00 | 81.00 | 60.00 | He et al., 2016 | HDMEC | 66.20 | 84.50 | Akkineni et al., 2016 | ||||||
| C2C12 | 80.00 | 90.00 | 94.00 | 98.00 | Bandyopadhyay et al., 2018 | A549 | 85.00 | 76.25 | Berg et al., 2018 | |||||
| ADMSCs | 88.13 | 90.41 | Wang et al., 2016 | ESCs | 92.00 | 91.50 | 87.75 | 85.50 | 86.25 | Li et al., 2018c | ||||
| *Ding et al., 2017, 2018; Aljohani et al., 2018 | ||||||||||||||
| AlginateGelMA | NIH3T3 | 90.00 | 75.00 | Krishnamoorthy et al., 2019 | BMSCs | 88.60 | 85.00 | 76.30 | Costantini et al., 2016 | |||||
| 89.00 | Zhang X. et al., 2018 | 84.50 | 80.50 | 78.00 | Kosik-Kozioł et al., 2019 | |||||||||
| MSCs | 81.25 | Daly et al., 2016a | ||||||||||||
| *Daly et al., 2016b; Kang et al., 2017; Liu et al., 2018 | ||||||||||||||
| Other | MSCs | 97.97 | Campos et al., 2015 | MG63 | 50.00 | 80.00 | 78.00 | Chen et al., 2018 | ||||||
| 88.00 | 90.00 | 90.00 | 90.00 | Xin et al., 2019 | 95.00 | 94.00 | 90.00 | Kim et al., 2016 | ||||||
| Chondrocytes | 93.00 | Ren et al., 2016 | C2C12 | 85.25 | Contessi Negrini et al., 2018 | |||||||||
| 94.00 | 85.00 | Censi et al., 2011 | PC12 | 98.00 | 94.00 | Chen et al., 2019 | ||||||||
| HSF | 90.00 | 85.00 | Bakirci et al., 2017 | NSCs | 41.70 | Lin et al., 2016 | ||||||||
| NIH3T3 | 85.00 | Wang et al., 2018 | HUASMCs | 90.00 | 82.00 | Köpf et al., 2016 | ||||||||
| ATDC5 | 90.00 | Kim et al., 2019 | BMSCs | 87.00 | 92.00 | 91.00 | Wu D. et al., 2018 | |||||||
| ADMSCs | 82.00 | Law et al., 2018 | MC3T3 | 88.00 | 91.00 | 88.00 | ||||||||
| HTC116 | 88.00 | 83.00 | 52.00 | 40.00 | Fan et al., 2016 | MSCs | 99.00 | 97 | Duarte Campos et al., 2013 | |||||
| BMSCs | 100.00 | 83.00 | Kiyotake et al., 2019 | MG63 | 99.00 | 95.00 | ||||||||
| NSCs | 87.00 | 55.00 | ||||||||||||
| *Hartwell et al., 2016; Ahn et al., 2017; Stichler et al., 2017; Cochis et al., 2018; Xu C. et al., 2018; Zheng et al., 2018; Li et al., 2019 | ||||||||||||||
All studies are included in the closest period when they used a different timing. References marked with (*) make viability assay but use multiple cell lines or conditions, or not provide any value.